According to Intellia Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.49 B. In 2022 the company made an earning of -$0.48 B a decrease over its 2021 earnings that were of -$0.27 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.49 B | 1.48% |
2022 | -$0.48 B | 77.01% |
2021 | -$0.27 B | 99.58% |
2020 | -$0.14 B | 34.86% |
2019 | -$99.54 M | 16.63% |
2018 | -$85.35 M | 26.35% |
2017 | -$67.55 M | 113.51% |
2016 | -$31.64 M | 135.92% |
2015 | -$13.41 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -76.98% | ๐บ๐ธ USA |